Liisa Elomaa
About
In The Last Decade
Liisa Elomaa
8 papers receiving 317 citations
Peers
Comparison fields: 5 of 48
- Oncology 215
- Cancer Research 187
- Pathology and Forensic Medicine 67
- Pulmonary and Respiratory Medicine 58
- Molecular Biology 50
Countries citing papers authored by Liisa Elomaa
This map shows the geographic impact of Liisa Elomaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liisa Elomaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liisa Elomaa more than expected).
Fields of papers citing papers by Liisa Elomaa
This network shows the impact of papers produced by Liisa Elomaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liisa Elomaa. The network helps show where Liisa Elomaa may publish in the future.
Co-authorship network of co-authors of Liisa Elomaa
This figure shows the co-authorship network connecting the top 25 collaborators of Liisa Elomaa. A scholar is included among the top collaborators of Liisa Elomaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liisa Elomaa. Liisa Elomaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Weekly paclitaxel--an effective treatment for advanced breast cancer. | 20 |
| 2 | 21 | |
| 3 | 11 | |
| 4 | 140 | |
| 5 | Paclitaxel-ifosfamide for anthracycline-resistant advanced breast cancer. | 2 |
| 6 | 63 | |
| 7 | 35 | |
| 8 | 41 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.